Abstract #3478
Quantification of Response of Hepatocellular Carcinoma(HCC) to Bevacizumab by Contrast Enhanced MRI
Mandeli J, Lehrer D, Cohen E, Schwartz J
Mount Sinai Medical Center
Quantiative assessment of effects of an anti-angiogenic agent on hepatocellular carcinoma by conrtast enhanced MRI demonstrating good correlation between change in size and degree of change in contrast enhancement.
